Suzhou, China

Xiaoxiao Ma


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Xiaoxiao Ma in Monoclonal Antibody Development

Introduction

Xiaoxiao Ma is a distinguished inventor based in Suzhou, China, known for his contributions to the field of biotechnology. With two patents to his name, he has made significant advancements in the development of monoclonal antibodies, which are crucial for therapeutic applications in treating various diseases, including tumors.

Latest Patents

Xiaoxiao Ma's latest patents focus on monoclonal antibodies designed to bind to specific antigens. The first patent details a monoclonal antibody that specifically binds to human and monkey CD38 antigens. This antibody incorporates specific antigen complementarity-determining regions (CDR) and has potential applications in treating tumors characterized by positive CD38 expression, such as human myeloma and human lymphoma.

The second patent involves a monoclonal antibody that binds to the human TIGIT antigen, which inhibits the ligand binding to CD155. This innovation provides a high-affinity solution and includes a humanization preparation method for the antibody. The development aims to facilitate treatment combinations with existing therapies, including anti-PD-1 monoclonal antibodies, for patients with tumors.

Career Highlights

Xiaoxiao Ma works for Acroimmune Biotech Co., Ltd., where he is recognized for his innovative contributions to monoclonal antibody research. His work reflects a commitment to advancing biotechnology that enhances treatment options for patients with serious diseases.

Collaborations

During his career, Xiaoxiao Ma has collaborated with notable colleagues such as Qunmin Zhou and Zui Chen. These collaborative efforts emphasize the importance of teamwork in the research and development of innovative therapeutic solutions.

Conclusion

Xiaoxiao Ma's contributions to monoclonal antibody development represent significant innovations in the field of biotechnology. His patents demonstrate the potential for these antibodies to transform treatment approaches for various tumors, highlighting the pivotal role of inventors in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…